542 related articles for article (PubMed ID: 16467662)
1. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
[TBL] [Abstract][Full Text] [Related]
2. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
[TBL] [Abstract][Full Text] [Related]
3. Decreased fracture risk in users of organic nitrates: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Bone Miner Res; 2006 Nov; 21(11):1811-7. PubMed ID: 17054422
[TBL] [Abstract][Full Text] [Related]
4. Reduced fracture risk in users of thiazide diuretics.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2005 Mar; 76(3):167-75. PubMed ID: 15719207
[TBL] [Abstract][Full Text] [Related]
5. Fracture risk in users of oral anticoagulants: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Int J Cardiol; 2007 Jun; 118(3):338-44. PubMed ID: 17055083
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive medications and risk of community-acquired pneumonia.
Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
[TBL] [Abstract][Full Text] [Related]
7. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
[TBL] [Abstract][Full Text] [Related]
8. Fracture risk in patients treated with loop diuretics.
Rejnmark L; Vestergaard P; Mosekilde L
J Intern Med; 2006 Jan; 259(1):117-24. PubMed ID: 16336519
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study.
Pasco JA; Henry MJ; Sanders KM; Kotowicz MA; Seeman E; Nicholson GC;
J Bone Miner Res; 2004 Jan; 19(1):19-24. PubMed ID: 14753732
[TBL] [Abstract][Full Text] [Related]
10. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
11. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
Liou YS; Ma T; Tien L; Lin CM; Jong GP
Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
[TBL] [Abstract][Full Text] [Related]
12. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
13. Long-term use of antihypertensive drugs and risk of cancer.
Assimes TL; Elstein E; Langleben A; Suissa S
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1039-49. PubMed ID: 18780400
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
[TBL] [Abstract][Full Text] [Related]
15. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
[TBL] [Abstract][Full Text] [Related]
16. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
[TBL] [Abstract][Full Text] [Related]
17. Reduced relative risk of fractures among users of lithium.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2005 Jul; 77(1):1-8. PubMed ID: 16007481
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
Bourgault C; Elstein E; Baltzan MA; Le Lorier J; Suissa S
Pharmacoepidemiol Drug Saf; 2001; 10(4):287-94. PubMed ID: 11760488
[TBL] [Abstract][Full Text] [Related]
19. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibitors and calcium channel blockers: patterns of use and associations with mortality in type 1 diabetes.
Sobolewski BA; Zgibor JC; Orchard TJ
Diabetes Res Clin Pract; 2004 Jul; 65(1):37-43. PubMed ID: 15163476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
